The meeting will feature a unique combination of brief research reports, oral presentations, keynote lectures, open discussion, brief didactic methods lectures, a poster session, and a webcast. These presentations will be peer-reviewed and will focus on the core controversies in Alzheimer’s disease biology and biomarker research. The aim is to continue the tradition of the first 13 HAI meetings, bringing together a cross-disciplinary mass of panelists and presenters who will provide perspectives from neuropathology, neurochemistry, psychology, neurology, molecular imaging, clinical trials and biomarker research.
Submission of abstracts was about 25 in 2007 and had grown to 210 by 2019. The Scientific Committee peer-reviews the online submitted abstracts (at least five reviewers per each abstract) and then selects those most suitable for talks and posters.
The poster sessions are typically a central event of the meeting, providing time for individual discussion with presenters.
Starting with 2017, and due to the growth of the event, we have scheduled three poster sessions. For 2020, we will host six 45-minute sessions scheduled for Wednesday, Thursday and Friday.
We will invite submission of abstracts in October.
All past abstracts and programs (2007 through 2019) are available for review from the conference website. We shall continue to post these abstracts following the actual events.
Abstract submission will open October 14, 2019 and will end November 4, 2019. The Abstract Review Committee will communicate the results by November 24, 2019. The HAI 2020 Program will be published on or around December 6, 2019.